Associations between cancer predisposition testing panel genes and breast cancer

FJ Couch, H Shimelis, C Hu, SN Hart, EC Polley… - JAMA …, 2017 - jamanetwork.com
Importance Germline pathogenic variants inBRCA1andBRCA2predispose to an increased
lifetime risk of breast cancer. However, the relevance of germline variants in other genes …

[HTML][HTML] A retrospective review of multiple findings in diagnostic exome sequencing: HalF. A. re distinct and halF. A. re overlapping diagnoses

ED Smith, K Blanco, SA Sajan, JM Hunter… - Genetics in …, 2019 - Elsevier
Purpose We evaluated clinical and genetic features enriched in patients with multiple
Mendelian conditions to determine which patients are more likely to have multiple potentially …

A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high …

H LaDuca, EC Polley, A Yussuf, L Hoang… - Genetics in …, 2020 - nature.com
Purpose Despite the rapid uptake of multigene panel testing (MGPT) for hereditary cancer
predisposition, there is limited guidance surrounding indications for testing and genes to …

[HTML][HTML] Navigating the nuances of clinical sequence variant interpretation in Mendelian disease

NT Strande, SE Brnich, TS Roman, JS Berg - Genetics in Medicine, 2018 - Elsevier
Understanding clinical genetic test results in the era of next-generation sequencing has
become increasingly complex, necessitating clear and thorough guidelines for sequence …

[HTML][HTML] Closing the gap: Systematic integration of multiplexed functional data resolves variants of uncertain significance in BRCA1, TP53, and PTEN

S Fayer, C Horton, JN Dines, AF Rubin… - The American Journal of …, 2021 - cell.com
Clinical interpretation of missense variants is challenging because the majority identified by
genetic testing are rare and their functional effects are unknown. Consequently, most …

Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results

M Pritzlaff, P Summerour, R McFarland, S Li… - Breast cancer research …, 2017 - Springer
Purpose Genetic predisposition to male breast cancer (MBC) is not well understood. The
aim of this study was to better define the predisposition genes contributing to MBC and the …

Multigene panel testing provides a new perspective on Lynch syndrome

CR Espenschied, H LaDuca, S Li… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Most existing literature describes Lynch syndrome (LS) as a hereditary syndrome
leading to high risks of colorectal cancer (CRC) and endometrial cancer mainly as a result of …

Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria

RM Xicola, S Li, N Rodriguez, P Reinecke… - Journal of medical …, 2019 - jmg.bmj.com
Background The clinical phenotype of CDH1 pathogenic variant carriers has mostly been
studied in families that fulfil criteria of hereditary diffuse gastric cancer (HDGC). We aimed at …

The contribution of germline predisposition gene mutations to clinical subtypes of invasive breast cancer from a clinical genetic testing cohort

C Hu, EC Polley, S Yadav, J Lilyquist… - JNCI: Journal of the …, 2020 - academic.oup.com
Background The germline cancer predisposition genes associated with increased risk of
each clinical subtype of breast cancer, defined by estrogen receptor (ER), progesterone …

Diagnostic outcomes of concurrent DNA and RNA sequencing in individuals undergoing hereditary cancer testing

C Horton, L Hoang, H Zimmermann, C Young… - JAMA …, 2024 - jamanetwork.com
Importance Personalized surveillance, prophylaxis, and cancer treatment options for
individuals with hereditary cancer predisposition are informed by results of germline genetic …